Bellevue Group’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $186K | Hold |
3,800
| – | – | ﹤0.01% | 127 |
|
|
2025
Q1 | $194K | Hold |
3,800
| – | – | ﹤0.01% | 133 |
|
|
2024
Q4 | $172K | Buy |
+3,800
| New | +$172K | ﹤0.01% | 144 |
|
|
2020
Q3 | – | Sell |
-56,800
| Closed | -$2.88M | – | 220 |
|
|
2020
Q2 | $2.88M | Sell |
56,800
-8,400
| -13% | -$426K | 0.04% | 130 |
|
|
2020
Q1 | $2.91M | Buy |
65,200
+9,100
| +16% | +$406K | 0.06% | 121 |
|
|
2019
Q4 | $2.69M | Sell |
56,100
-25,100
| -31% | -$1.21M | 0.04% | 123 |
|
|
2019
Q3 | $2.75M | Sell |
81,200
-2,300
| -3% | -$77.8K | 0.05% | 123 |
|
|
2019
Q2 | $3.76M | Buy |
83,500
+48,800
| +141% | +$2.2M | 0.06% | 114 |
|
|
2019
Q1 | $1.31M | Buy |
34,700
+13,000
| +60% | +$489K | 0.07% | 119 |
|
|
2018
Q4 | $745K | Sell |
21,700
-800
| -4% | -$27.5K | 0.05% | 125 |
|
|
2018
Q3 | $1.06M | Buy |
+22,500
| New | +$1.06M | 0.07% | 126 |
|
|
2016
Q2 | – | Sell |
-35,000
| Closed | -$225K | – | 130 |
|
|
2016
Q1 | $225K | Buy |
+35,000
| New | +$225K | 0.04% | 120 |
|